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the sternum veins bears some similarity to the opening of the
cranial vault veins, and disconnecting the endotracheal tube just
before sternotomy decreases airway pressure. Furthermore, 5
(25%) of our patients had a preexisting right-to-left shunt, again
increasing the likelihood of clinically significant VAE. The fact
that embolus incidence was higher with the saw compared with the
scissors is not straightforward. It would seem that the saw would
result in less compression of the bone marrow, thus being less
traumatic. One may hypothesize that the vibration caused by the
saw action induces microbubble formation such as in agitated
saline. This hypothesis was tested by pressing the saw against the
closed chest wall, thus testing the effects of the vibrations alone.
No emboli were detected. Another explanation might be that the
vibrations cause increased small amounts of air entrainment in the
open vessels. This hypothesis has not been tested. In summary, our
results suggest that VAE during sternotomy is a frequent occur-
rence and that the number of emboli is related to the method of
sternotomy.
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First human transplantation of a bioengineered airway tissue
Paolo Macchiarini, MD, PhD,a,b Thorsten Walles, MD,a,b Christian Biancosino,b and Heike Mertsching, PhD,b
Hannover, Germany
Airway defects occurring at the anastomotic site aftercarinal pneumonectomy are associated with persistentcontamination between airway and pleural spaces,mediastinal spaces, or both and difficulties in the
re-expansion of and possible aspiration into the residual lung.
Unfortunately, therapeutic interventions are limited, and the out-
come is often fatal.1 An ideal solution would be to generate an
airway segment or surface to be implanted after achieving control
of the infection and aspiration. Tissue-engineered airway is about
the only technique of the many attempts at tracheal replacement
that seems to offer any real promise.2 It applies the principles of
engineering and life sciences toward the development of biologic
substitutes that restore, maintain, or improve tissue function and
offers the potential to create replacement structures from biode-
gradable scaffolds and autologous cells.3 We here describe the first
clinical application of a tissue engineered airway patch.
Clinical Summary
A 58-year-old man was admitted in April 2003 complaining of
general weakness, coughing up of pus, temperature of greater than
39°C, shortness of breath, and intolerable halitosis. He had under-
gone a right completion carinal pneumonectomy and radical
lymphadenectomy for a relapsing non–small cell lung cancer
pathologically staged as T4 N0 M0 in March 2003. He had had an
upper bilobectomy and adjuvant radiation therapy (60 Gy) for an
non–small cell lung cancer of equal histotype staged as T3 N2 in
1999. On chest radiography, the air-fluid pleural level in the
postpneumonectomy space vanished, and the contralateral left
lower lobe showed infiltrative signs suggestive of aspiration pneu-
monitis. Bronchoscopy showed a complete dehiscence of the ven-
trolateral aspect of the tracheobronchial anastomosis measuring 2
 2 cm, communicating directly with the residual pleural space.
Because Pseudomonas aeruginosa strains were found in the pleu-
ral space and blood, the diagnosis of pleural empyema and pyo-
septicemia was made, and the decision was taken to perform both
ventral and dorsal open thoracostomies. The patient was further
treated medically with the intent to sterilize the residual pleural
space, prevent bacterial contamination of the residual left lung, and
obtain a spontaneous closure of the anastomotic dehiscence.
The patient’s general conditions improved slowly to an extent
that his pleural space was uncontaminated, and his pyosepticemia
resolved. However, on the basis of the previous bad clinical
experiences,1 written informed consent was obtained to take, after
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Figure 1. Process of engineering the bioartificial patch. Muscle cells and fibroblasts are isolated from a biopsy
specimen obtained from the patient. These cells are seeded on a biologic matrix representing a collagen network
generated from a decellularized porcine jejunal segment. During the incubation period, the cells start to remodel
the xenogenic matrix and replace it with autologous connective tissue. Within 4 weeks, this autologous
bioartificial implant can be clinically used. The computed tomographic scan of the chest 6 weeks after graft
implantation shows the site (arrow) where the tissue-engineered patch was transplanted. The right pleural cavity
is completely filled with the transposed omentum major and right subscapular muscle.
Figure 2. Histologic composition of the bioartificial patch. A, Acellular porcine collagen matrix. (Original magni-
fication 200 hematoxylin and eosin staining.) Notice the absence of cellular components and the red-stained
collagen fibers. B, Reseeded patch before implantation. Antivimentin immunohistology depicting fibroblast and
smooth muscle cell seeding. (Original magnification 200.) C, Brush cytology from the patch surface showing
respiratory epithelium (12th week). Arrows indicate epithelial cilia. D, Immunhistochemical staining for respiratory
epithelium (12th week). (Original magnification 200; Villin antibody.)
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achievement of local anesthesia, tissue samples at the thoracos-
tomy sites with the intent to generate a bioengineered airway tissue
that could then be transplanted to close the anastomotic defect
(Figure 1). The patient was then discharged. We isolated muscle
cells and fibroblasts from the biopsy samples by means of trypsin–
ethylenediamine tetraacetic acid digestion and expanded the cul-
tured cells in vitro. After 3 weeks (third cell passage), 1.5 million
cells were seeded on a 24 36–mm matrix (5% muscle cells/95%
fibroblasts). This carrier structure consisted of a collagen network
that was generated from a decellularized porcine proximal jejunum
segment (Figure 2, A and B). The resulting bioartificial construct
was incubated for another 3 weeks in a bioreactor to control cell
proliferation and to allow functional tissue formation by extracel-
lular matrix turnover.4 Its maximal in vitro tolerance to pressure
forces was then evaluated and found to be 300 mm Hg.
Five weeks later, the patient was readmitted for final defect
closure. The results of clinical examination and blood tests were
unremarkable, as were the results of complete tumor staging.
Brush cytology of the pleural cavity showed normal respiratory
bacterial fauna and no evidence of any pathogenic bacterial colo-
nization. Endoscopy showed a minimal reduction in the size of the
airway defect and ruled out infections of the residual left lung. The
patient underwent surgical intervention through the previous tho-
racotomy incision. The defect was immediately identified and
mobilized, and the dehiscence was completely opened so that it
could be measured as being 1.5  1.5 cm large. The pleural
surface was debrided. The generated tissue-engineered segment
was folded medially to double the graft’s thickness and trans-
planted over the dehiscence by fixing it circumferentially to the
neighboring mediastinal tissue with 4-0 polyglactin (Vicryl; Ethi-
con Inc, Sommerville, NJ) interrupted sutures anchored. Air tight-
ness was confirmed intraoperatively, and the operation was com-
pleted with an omentum major and right subscapular myoplasty
transposition and tailored thoracoplasty (second to fifth ribs). Both
open thoracostomies were closed as well. The patient was extu-
bated at the end of the operation and transferred to the surgical
intensive care unit. Within the first hour after the operation, the
patient had an acute pulmonary edema that was successfully
treated with dehydratation. The patient was transferred to the
normal ward on the fifth postoperative day. The further postoper-
ative course was uneventful, and the patient was discharged the
third postoperative week. Control endoscopies with brush cytolo-
gies of the native trachea and transplanted patch were performed
on the first postoperative week and after 3, 6, and 12 weeks on an
outpatient basis. Cytologies were evaluated for reseeding cell type
and viability. Pulmonary function tests and chest computed tomog-
raphy were performed after 3, 6, 12, and 24 weeks.
Results
The patient can perform regular physical activity, enjoys hunting,
and speaks with a sturdy voice. His quality of life has returned to
normal. Clinical examination has been unremarkable, as has post-
pneumonectomy lung function. Control endoscopy on the fifth
postoperative day showed a tight airway covered by a normal
mucosa and a graft that was laterally rigid but longitudinally
flexible, therefore synchronizing the inspiratory and expiratory
movements. The graft’s endoluminal aspect was surfaced with
viable ciliated respiratory epithelium: its cellular density was 80%
of that of the native trachea, and cell viability was almost 100%.
Outpatient endoscopies on the 3rd, 6th, and 12th postoperative
weeks confirmed the above early postoperative findings and
showed that the graft was airtight and surfaced with autologous
ciliated respiratory epithelium (Figure 2, C and D), with no evi-
dence of chronic inflammation, granulation tissue, infection, or
erosion. Vascular ingrowth was detectable from the patch margins
as soon as by the 6th week and completed by the 12th postoper-
ative week. After 12 weeks, the entire patch was functionally and
morphologically completely integrated into the adjacent airway.
Chest computed tomography documented complete filling of the
right pleural cavity.
Discussion
Tissue engineering implies formation of manmade functional bi-
ologic organs or tissue replacements by autologous cells intro-
duced into a framework of biodegradable or biologic carrier struc-
tures, the so-called matrices.3 The advantages of the matrices are
their biocompatibility, bioabsorbability, nonimmunogenity, sup-
port of cell attachment and growth, and ability to induce angio-
genesis.
The tissue-engineered airway patch used here was made from
autologous muscle cells and fibroblasts seeded on a sufficiently
large (24  36 mm) matrix consisting of a collagen network
generated from a decellularized porcine proximal jejunum seg-
ment. This bioartificial graft was then successfully clinically trans-
planted. The time frame needed to prepare it was clinically satis-
factory because it allowed the infection of the residual pleural
space and contralateral aspiration pneumonitis to subside, the
patients’ general conditions to improve, and the defect to stabilize.
Its technical transplantation was surgically straightforward,
avoided the very risky mediastinal dissection,1 and immediately
guaranteed an airtight airway. Repeated bronchoscopies proved
permanent closure of the defect and evidenced the graft’s neovas-
cularization in vivo. Most interestingly, however, was the demon-
stration that the tissue-engineered patch (1) was reseeded with
functional ciliated respiratory epithelium, (2) had a cellular density
equal to 80% of the native trachea, and (3) had almost entirely
viable cells, and this was within the fifth postoperative day. This
provides definitive evidence that a tissue-engineered airway patch
with the dimensions used here can functionally survive and com-
pletely fills all requirements for an airway patch. A possible
explanation for this phenomenon could be that the ingrowth of the
respiratory epithelium from the normal tracheal ends alone was
favored by the permanent viability of the bioengineered tissue. If
this hypothesis holds true, there is no need for epithelial coverage
and direct or indirect revascularization for tissue-engineered air-
way grafts of the dimensions used above.5
Conclusions
This anecdotal but encouraging experience unlocks the door for
the clinical application of bioengineered airway tissue in other
pediatric and adult pathologies in which therapeutic interventions
are limited.
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Two-conduit repair for anomalous origin of the
left coronary artery from the pulmonary artery
in an adult
Hassan Kattach, MD, MRCS, Kyriakos Anastasiadis, MD, Xu Yu Jin, PhD, and
Ravi Pillai, FRCS, Oxford, United Kingdom
Anomalous origin of the left coronary artery from thepulmonary artery (ALCAPA) presenting in adultlife is rare. Although it is surgically treated in mostcases, the preferred procedure offering the best
short- and long-term outcomes is still unknown. We present the
case of a patient who was successfully treated by a 2-conduit
repair.
Clinical Summary
A 41-year-old previously healthy man presented with acute onset
chest pain and left bundle branch block on his electrocardiogram.
No increase of cardiac enzymes was detected. Echocardiogram
showed a dilated and severely impaired left ventricle, but all valves
were normal. Cardiac catheterization demonstrated a grossly di-
lated right coronary artery. The contrast material retrogradely filled
a dilated left coronary system through the collateral vessels.
The left coronary system in turn drained into the pulmonary
artery (PA) (Fig 1). A contrast computed tomographic scan
confirmed that the left coronary artery (LCA) was arising from
the PA.
Surgical procedure. Anatomically it was not possible to trans-
locate the LCA. Therefore, an intrapulmonary tunnel was con-
structed by first creating an aortopulmonary window; then, with a
PA homograft patch as a baffle, the window was connected to the
LCA ostium. In addition, the left internal thoracic artery (LITA)
was grafted to the left
anterior descending ar-
tery (LAD). The pa-
tient made an unevent-
ful recovery.
Coronary angiography was performed 6 months postopera-
tively and showed a patent intrapulmonary tunnel supplying the
circumflex system and a patent LITA graft to the LAD. It also
revealed a reduction in size of the coronary arteries (Fig 2). Left
ventricular function improved (ejection fraction increased from
30% preoperatively to 40% postoperatively, and left ventricular
end-diastolic diameter was mildly decreased from 65 to 60 mm on
echocardiogram). In addition, the stress myocardial perfusion
study demonstrated good perfusion, with no evidence of scarring.
Clinically, the patient reported continued improvement in exercise
tolerance.
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doi:10.1016/j.jtcvs.2004.03.050 Figure 1. Right coronary artery angiogram. Dilated right coronary
artery (R) fills the LCA system (L) by collateral vessels (arrow).
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